Articles from VivoSim

As the FDA opens the door to non-animal safety testing, VivoSim's executive chairman argues the agency needs to recognize that some non-animal assays already have sufficient qualification to start requiring them, in order to demonstrate safety and to slow the steady flow of toxic compounds still found in human clinical testing.